Biofrontera Inc. (BFRI) Announces $16M Private Placement

Go back to Biofrontera Inc. (BFRI) Announces $16M Private Placement

Biofrontera Inc. Announces Private Placement of Up To $16.0 Million Priced at Market per Nasdaq Rules

February 20, 2024 8:08 AM UTC

Company secures financing of $8.0 million with an additional $8.0 million second tranche tied to milestones for aggregate proceeds of $16 million gross priced at market per Nasdaq rulesFunding and recent restructuring of supply agreement allow Biofrontera Inc to assume R&D activities and to support further commercial growth

WOBURN, MA / ACCESSWIRE / February 20, 2024 / Biofrontera Inc. (NASDAQ: BFRI) ("Biofrontera" or the "Company") , a biopharmaceutical company specializing in the commercialization of dermatologic products, today announced it has entered into a securities purchase agreement with healthcare-focused... More